
Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. (PHIO)
WebsitePrice
Market cap
Next catalystExpected Q1 2027PH-762 — planned Phase 2b neoadjuvant cSCC study · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved